相关实验视频

Updated: Jun 14, 2025

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.4K

对Ce-lamin/LMN-1产生一种高特异性和强大的抗体

Adam Zahand1, Byron Williams1, Jun Liu1

  • 1Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.

microPublication biology
|September 2, 2024
PubMed
概括

新的几内亚猪抗体准Ce-lamin/LMN-1蛋白,揭示了其在整个发育过程中的显著稳定性. 这种蛋白质甚至存在于缺乏LMN-1基因的成年突变体中.

更多相关视频

Generation of Murine Monoclonal Antibodies by Hybridoma Technology09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.6K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

18.4K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K